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sPrevalence and Clinical Consequences of Carotid Artery Residual
Defects Following Endarterectomy: A Prospective CT Angiography
Evaluation Study
van der Kolk A.G., de Borst G.J., Jongen L.M., denHartog A.G., Moll F.L.,
Mali W.P.Th.M., Hendrikse J. Eur J Vasc Endovasc Surg 2011;42:145-53.
Objectives: It is still unclear whether residual defects seen after carotid
endarterectomy (CEA) have clinical consequences. We investigated preva-
lence of residual defects in the carotid artery and their possible impact on
clinical and Duplex ultrasound (DUS) follow-up.
Materials and methods: Sixty-five patients who had undergone CEA
were prospectively examined with 1–3 month postoperative computed
tomographic angiography (CTA), clinical and DUS follow-up. Defects in
common (CCA), external (ECA) and internal carotid artery (ICA) were
scored as clamp marks, intimal step or flap, mural thrombus, kink, microde-
hiscence suture or residual stenosis.
Results: Fifty-eight patients (89.2%) had residual defects in CCA, ECA
or ICA (143 defects). Intimal steps (n  39) and residual stenosis (n  17)
were most noted defects. Only residual defects in ECA were significantly
associated with significant higher PSV values both at short-term and long-
term follow-up (1990 vs. 1400 mm s1 at 1 year and 2000 vs. 1230 mm s1
at 2 years, P-values 0.031 and 0.016).
Conclusion: Carotid artery residual defects on CTA after CEA are very
common, simple fingerprints of the operative procedure, have no clear
consequence. When CTA is performed clinically after CEA, knowledge of
high prevalence and type of defects detected on CTA may be of importance
for radiologists and clinicians.
Endovascular Repair of Aorto-iliac Artery Injuries after Lumbar-spine
Surgery
CanaudL.,HirecheK., Joyeux F.,D’Annoville T., Berthet J.-P.,Marty-AnéC.,
Alric P. Eur J Vasc Endovasc Surg 2011;42:168-72.
Objective: This study aims to describe the endovascular management
of abdominal-aortic- or common-iliac-artery injuries after lumbar-spine
surgery.
Methods: Patients treated for abdominal-aortic- or common-iliac-
artery injuries after lumbar-spine surgery during a 13-year period were
identified from an endovascular database, providing prospective information
on techniques and outcome. The corresponding patient records and radio-
graphic reports were analysed retrospectively.
Results: Seven patients were treated with acute (n  3) or subacute
(n  4) injuries of the common iliac artery (n  6) or abdominal aorta
(n  1) after lumbar-spine surgery. Vascular injuries included arterial lacer-
ations (n  3), arteriovenous fistulas (n  2) and pseudo-aneurysms
(n  2). The mean age of the patients was 51.7 years (30–60 years), 71.4%
were women. These lesions were repaired by transluminal placement of stent
grafts: Passager (n  3), Viabahn (n  1), Wallgraft (n  1), Zénith
(n  1) and Advanta V12 (n  1). Exclusion of the injury was achieved in all
cases. Mortality was nil. There were no procedure-related complications.
During a median follow-up of 8.7 years (range 0.3–13 years), all stent grafts
remained patent.
Conclusions: Sealing of common iliac artery or abdominal aortic
lesions as a complication of lumbar-disc surgery with a stent graft is effective
and is suggested as an excellent alternative to open surgery for iatrogenic
great-vessel injuries, particularly in critical conditions.
Use of ViaBahn Open Revascularisation Technique for Above-knee
Femoro-popliteal Anastomosis: A Technical Note
Greenberg G., Szendro G., Mayzler O., Ginzburg V., Leytzin A. Eur J Vasc
Endovasc Surg 2011;42:203-6.
We describe a ViaBahn Open Revascularization TEChnique (VORTEC)
application in peripheral femoro-popliteal polytetrafluoroethylene (PTFE) graft
bypass in 13 patients.
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584alking Performance and Health-related Quality of Life after Surgical
r Endovascular Invasive versus Non-invasive Treatment for Intermit-
ent Claudication – A Prospective Randomised Trial
ordanstig J., Gelin J., Hensäter M., Taft C., Österberg K., Jivegård L. Eur
Vasc Endovasc Surg 2011;42:221-8.
Objectives: Despite limited scientific evidence for the effectiveness of
nvasive treatment for intermittent claudication (IC), revascularisation pro-
edures for IC are increasingly often performed in Sweden. This randomised
ontrolled trial compares the outcome after 2 years of primary invasive
INV) versus primary non-invasive (NON) treatment strategies in unse-
ected IC patients.
Materials/Methods: Based on arterial duplex and clinical examina-
ion, IC patients were randomised to INV (endovascular and/or surgical,
 100) or NON (n  101). NON patients could request invasive treat-
ent if they deteriorated during follow-up. Primary outcome was maximal
alking performance (MWP) on graded treadmill test at 2 years and second-
ry outcomes included health-related quality of life (HRQL), assessed with
hort Form (36) Health Survey (SF-36).
Results: MWP was not significantly (p  0.104) improved in the INV
ersus the NON group. Two SF-36 physical subscales, Bodily Pain
p  0.01) and Role Physical (p  0.05) improved significantly more in the
NV versus the NON group. There were 7% crossovers against the study
rotocol in the INV group.
Conclusions: Although invasive treatment did not show any signifi-
ant advantage regarding MWP, the HRQL improvements associated with
nvasive treatment tentatively suggest secondary benefits of this regimen. On
he other hand, a primary non-invasive treatment strategy seems to be
ccepted by most IC patients.
nfluence of Use of a Vascular Closure Device on Incidence and
urgical Management of Access Site Complications after Percutaneous
nterventions
locker J., Gratl A., Chemelli A., Moes N., Goebel G., Fraedrich G. Eur J
asc Endovasc Surg 2011;42:231-6.
Aim: The study aimed to evaluate vascular access site complications
ASCs) after percutaneous interventions (PIs) in our institution for changes
n annual incidence and surgical management after increased usage of a
ascular closure device (VCD; in all cases: Angioseal™).
Material and Methods: All patients who underwent repair of arterial
seudo-aneurysms or access site stenosis/occlusion leading to leg ischaemia
LI) or new-onset disabling claudication (CI) after PIs between 2001 and
008 were included. Annual rates of procedures and methods of repair of
SC were evaluated.
Results: After a total of 58 453 PIs, 352 patients (0.6%) were operated
n for: pseudo-aneurysms (n  300; 0.51%); and local stenosis/occlusion
eading to LI/CI (n  52; 0.09%). Numbers increased significantly with
ore widespread VCD use: group A (2001–2004: 2860 VCDs; 28 284 PIs;
0.1%): n  132 (0.47%); and group B (2005–2008: 11,660 VCDs; 30,169
Is; 38.6%): n  220 (0.73%) (p  0.001). In contrast to similar rates of
seudo-aneurysms (group A: n  124; 0.44%; group B: n  176; 0.58%;
ot significant), a significant increase of operations for local stenoses/
cclusions was seen with widespread VCD use: n  8 versus n  44
p  0.001).
Conclusions: In the era of VCDs, complications are rare. However,
se of these devices is not without complications, and may require complex
econstructions.
n Vivo Biological Effects of Foam Sclerotherapy
amel-Desnos C.M., Desnos P.R., Ferre B., Le Querrec A. Eur J Vasc
ndovasc Surg 2011;42:239-46.
Objectives: This study aims to assess by biological markers the in vivo
onsequences of foam sclerotherapy (FS) of saphenous veins. The secondary
bjective of this randomised controlled trial (RCT) is to compare results of
wo randomised groups: with or without post-treatment compression.
Patients and methods: Forty patients with incompetent great or small
aphenous veins underwent ultrasound-guided FS. Randomisation was con-
ucted immediately after sclerotherapy to two parallel groups, one (CG)
ith compression stockings and the other (WCG) without compression.
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Volume 54, Number 2 Abstracts 585A laboratory work-up was done on days 0 (before sclerotherapy), 1,
7, 14 and 28. The studied markers were: fibrinogen, factor VIII, throm-
bomodulin, thrombin–antithrombin complex, D-dimers, platelet factor
4 and troponin.
Results: General data repartition was homogenous for CG and WCG.Readers can access EJVES articles at http://intl.eroups. In all the samples (D0–D28), apart from a moderate D-dimers’
ncrease at D1–D14, no significant biological change was observed in either
he WCG or the CG groups.
Conclusion: In terms of inflammation and coagulation, FS seems to
ave a minimal effect on peripheral blood, either with or without post-Twenty patients were included in each group (females 90%; mean age 58
years). On day 28 (D28), the occlusion rate of the veins was 100% in both
treatment compression and does not appear to have an effect on the
myocardial risk.lsevierhealth.com/journals/ejvs/default.cfm
